REPORT ID 3830

EMEA (Europe, Middle East and Africa) Soluble Guanylate Cyclase Market Report 2017

Publish Date
14-Dec-17
Pages
102
Format
Electronic (PDF)

In this report, the EMEA Soluble Guanylate Cyclase market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Soluble Guanylate Cyclase for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Soluble Guanylate Cyclase market competition by top manufacturers/players, with Soluble Guanylate Cyclase sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Bayer AG
    Boehringer Ingelheim GmbH
    Ironwood Pharmaceuticals Inc
    NicOx SA
    SynZyme Technologies LLC
    Topadur Pharma AG
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    BAY-1636183
    BI-703704
    Hydroxyurea
    IW-1701
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Cardiovascular
    Ophthalmology
    Metabolic Disorders
    Gastrointestinal
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Soluble Guanylate Cyclase Market Report 2017
1 Soluble Guanylate Cyclase Overview
    1.1 Product Overview and Scope of Soluble Guanylate Cyclase
    1.2 Classification of Soluble Guanylate Cyclase
        1.2.1 EMEA Soluble Guanylate Cyclase Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Soluble Guanylate Cyclase Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 BAY-1636183
        1.2.4 BI-703704
        1.2.5 Hydroxyurea
        1.2.6 IW-1701
        1.2.7 Others
    1.3 EMEA Soluble Guanylate Cyclase Market by Application/End Users
        1.3.1 EMEA Soluble Guanylate Cyclase Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Cardiovascular
        1.3.3 Ophthalmology
        1.3.4 Metabolic Disorders
        1.3.5 Gastrointestinal
        1.3.6 Others
    1.4 EMEA Soluble Guanylate Cyclase Market by Region
        1.4.1 EMEA Soluble Guanylate Cyclase Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Soluble Guanylate Cyclase (2012-2022)
        1.5.1 EMEA Soluble Guanylate Cyclase Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Soluble Guanylate Cyclase Revenue and Growth Rate (2012-2022)

2 EMEA Soluble Guanylate Cyclase Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Soluble Guanylate Cyclase Market Competition by Players/Manufacturers
        2.1.1 EMEA Soluble Guanylate Cyclase Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Soluble Guanylate Cyclase Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Soluble Guanylate Cyclase Sale Price by Players (2012-2017)
    2.2 EMEA Soluble Guanylate Cyclase (Volume and Value) by Type/Product Category
        2.2.1 EMEA Soluble Guanylate Cyclase Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Soluble Guanylate Cyclase Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Soluble Guanylate Cyclase Sale Price by Type (2012-2017)
    2.3 EMEA Soluble Guanylate Cyclase (Volume) by Application
    2.4 EMEA Soluble Guanylate Cyclase (Volume and Value) by Region
        2.4.1 EMEA Soluble Guanylate Cyclase Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Soluble Guanylate Cyclase Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Soluble Guanylate Cyclase Sales Price by Region (2012-2017)

3 Europe Soluble Guanylate Cyclase (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Soluble Guanylate Cyclase Sales and Value (2012-2017)
        3.1.1 Europe Soluble Guanylate Cyclase Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Soluble Guanylate Cyclase Revenue and Growth Rate (2012-2017)
    3.2 Europe Soluble Guanylate Cyclase Sales and Market Share by Type
    3.3 Europe Soluble Guanylate Cyclase Sales and Market Share by Application
    3.4 Europe Soluble Guanylate Cyclase Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Soluble Guanylate Cyclase Sales Volume by Countries (2012-2017)
        3.4.2 Europe Soluble Guanylate Cyclase Revenue by Countries (2012-2017)
        3.4.3 Germany Soluble Guanylate Cyclase Sales and Growth Rate (2012-2017)
        3.4.4 France Soluble Guanylate Cyclase Sales and Growth Rate (2012-2017)
        3.4.5 UK Soluble Guanylate Cyclase Sales and Growth Rate (2012-2017)
        3.4.6 Russia Soluble Guanylate Cyclase Sales and Growth Rate (2012-2017)
        3.4.7 Italy Soluble Guanylate Cyclase Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Soluble Guanylate Cyclase Sales and Growth Rate (2012-2017)

4 Middle East Soluble Guanylate Cyclase (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Soluble Guanylate Cyclase Sales and Value (2012-2017)
        4.1.1 Middle East Soluble Guanylate Cyclase Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Soluble Guanylate Cyclase Revenue and Growth Rate (2012-2017)
    4.2 Middle East Soluble Guanylate Cyclase Sales and Market Share by Type
    4.3 Middle East Soluble Guanylate Cyclase Sales and Market Share by Application
    4.4 Middle East Soluble Guanylate Cyclase Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Soluble Guanylate Cyclase Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Soluble Guanylate Cyclase Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Soluble Guanylate Cyclase Sales and Growth Rate (2012-2017)
        4.4.4 Israel Soluble Guanylate Cyclase Sales and Growth Rate (2012-2017)
        4.4.5 UAE Soluble Guanylate Cyclase Sales and Growth Rate (2012-2017)
        4.4.6 Iran Soluble Guanylate Cyclase Sales and Growth Rate (2012-2017)

5 Africa Soluble Guanylate Cyclase (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Soluble Guanylate Cyclase Sales and Value (2012-2017)
        5.1.1 Africa Soluble Guanylate Cyclase Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Soluble Guanylate Cyclase Revenue and Growth Rate (2012-2017)
    5.2 Africa Soluble Guanylate Cyclase Sales and Market Share by Type
    5.3 Africa Soluble Guanylate Cyclase Sales and Market Share by Application
    5.4 Africa Soluble Guanylate Cyclase Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Soluble Guanylate Cyclase Sales Volume by Countries (2012-2017)
        5.4.2 Africa Soluble Guanylate Cyclase Revenue by Countries (2012-2017)
        5.4.3 South Africa Soluble Guanylate Cyclase Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Soluble Guanylate Cyclase Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Soluble Guanylate Cyclase Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Soluble Guanylate Cyclase Sales and Growth Rate (2012-2017)

6 EMEA Soluble Guanylate Cyclase Manufacturers/Players Profiles and Sales Data
    6.1 Bayer AG
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Soluble Guanylate Cyclase Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Bayer AG Soluble Guanylate Cyclase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Boehringer Ingelheim GmbH
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Soluble Guanylate Cyclase Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Boehringer Ingelheim GmbH Soluble Guanylate Cyclase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Ironwood Pharmaceuticals Inc
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Soluble Guanylate Cyclase Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Ironwood Pharmaceuticals Inc Soluble Guanylate Cyclase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 NicOx SA
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Soluble Guanylate Cyclase Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 NicOx SA Soluble Guanylate Cyclase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 SynZyme Technologies LLC
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Soluble Guanylate Cyclase Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 SynZyme Technologies LLC Soluble Guanylate Cyclase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Topadur Pharma AG
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Soluble Guanylate Cyclase Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Topadur Pharma AG Soluble Guanylate Cyclase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    ...

7 Soluble Guanylate Cyclase Manufacturing Cost Analysis
    7.1 Soluble Guanylate Cyclase Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Soluble Guanylate Cyclase

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Soluble Guanylate Cyclase Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Soluble Guanylate Cyclase Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Soluble Guanylate Cyclase Market Forecast (2017-2022)
    11.1 EMEA Soluble Guanylate Cyclase Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Soluble Guanylate Cyclase Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Soluble Guanylate Cyclase Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Soluble Guanylate Cyclase Price and Trend Forecast (2017-2022)
    11.2 EMEA Soluble Guanylate Cyclase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Soluble Guanylate Cyclase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Soluble Guanylate Cyclase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Soluble Guanylate Cyclase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Soluble Guanylate Cyclase Sales Forecast by Type (2017-2022)
    11.7 EMEA Soluble Guanylate Cyclase Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer